Welcome to our dedicated page for Rubicon Organics news (Ticker: ROMJF), a resource for investors and traders seeking the latest updates and insights on Rubicon Organics stock.
Rubicon Organics Inc. (ROMJF) operates at the forefront of Canada's premium cannabis market, specializing in organic cultivation and innovative product development. This news hub provides investors and industry professionals with essential updates about the company's strategic initiatives, regulatory compliance, and market positioning.
Access consolidated coverage of operational milestones including cultivation advancements, product line expansions, and financial performance. Our repository ensures efficient tracking of Rubicon Organics' progress in key areas such as quality-focused production, supply chain optimization, and brand portfolio management.
Key updates include earnings reports, regulatory filings, partnership announcements, and product innovation launches. Each news item is curated to reflect the company's commitment to operational excellence in the competitive cannabis sector.
Bookmark this page for streamlined access to Rubicon Organics' official communications and third-party analyses. Regularly updated content supports informed decision-making for stakeholders monitoring the evolving cannabis industry landscape.
Rubicon Organics (OTCQX: ROMJF), Canada's leading premium organic cannabis producer, reported strong Q2 2025 financial results with net revenue of $15.0 million, up 24% year-over-year. The company achieved Adjusted EBITDA of $1.4 million and positive operating cash flow of $0.8 million.
Key developments include the acquisition of the Hope Facility, increasing production capacity by 40% to 15,500 kg annually, and completion of a $4.5 million private placement. The company expanded its product portfolio with the launch of 1964 Premium All-in-One Resin Vapes and maintained strong market share positions: 5.2% in premium flower/pre-rolls, 15.1% in resin vapes, and 26.2% in premium edibles.
For 2025, Rubicon expects growth in both revenue and Adjusted EBITDA, despite anticipated one-time costs of $1-2 million related to the Hope Facility start-up. The company is also exploring international market opportunities while maintaining focus on Canadian market leadership.
Rubicon Organics (OTCQX:ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has scheduled its Q2 2025 financial results release for August 18, 2025, before market open.
The company will host a conference call to discuss the results on the same day at 7:00 AM PT / 10:00 AM ET. Investors can access the call through local dial-in, toll-free North American number, or via webcast through the company's earnings call registration.
Rubicon Organics (OTCQX: ROMJF), a premium cannabis producer, held its Annual General and Special Meeting with 46.3% shareholder representation. Shareholders approved all proposed matters, including setting the board size at eight directors and electing all nominated directors with approval rates ranging from 85.7% to 95.8%.
The company announced a significant leadership change as Len Boggio steps down as Board Chair, transitioning to Chair of the Nomination and Governance Committee. Doris Bitz, an independent director since 2023 with over 30 years of CPG and manufacturing experience, has been appointed as the new Board Chair.
Shareholders also approved amendments to the company's Omnibus Equity Incentive Plan with 74.7% support. The plan allows for a maximum of 8,960,180 Common Shares for equity awards. Additionally, the company granted 1,024,576 DSUs to independent directors, vesting in twelve months.
Rubicon Organics (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis, has announced its upcoming Annual General and Special Meeting scheduled for July 31, 2025, at 10:00 AM PT. The meeting will be held at the Terminal City Club in Vancouver, with a live webcast option available.
The meeting agenda includes receiving 2024 financial statements, setting the board size at eight directors, electing directors, appointing PricewaterhouseCoopers LLP as auditors, and considering an amendment to the Omnibus Equity Incentive Plan to reserve 8,960,179 Common Shares for issuance. The record date for the meeting was set for June 25, 2025.
Rubicon Organics (OTCQX: ROMJF) has announced the launch of its new 1964 Supply Co.™ All-in-One (AIO) Full Spectrum Extract (FSE) Resin Vapes in the Canadian market. The product features the Comatose strain in a 0.5 gram format and will initially launch in British Columbia before expanding to other major Canadian provinces, excluding Quebec.
The launch follows the successful introduction of 510 FSE resin vape cartridges in May 2024. The company plans to launch two additional AIO offerings by the end of 2025. The product aims to attract legacy market consumers by offering high-quality FSE resin vapes at competitive price points, distinguishing itself in a market dominated by distillate-based products.
Rubicon Organics (ROMJF) has cleared all conditions precedent for acquiring the Hope Facility from Medipharm Labs Inc. The facility is a 47,500 square foot indoor cultivation facility located in Hope, British Columbia. This strategic acquisition is expected to significantly expand Rubicon's premium cannabis production capacity.
The company, which specializes in organic certified and premium cannabis products, anticipates closing the acquisition in the second quarter. CEO Margaret Brodie emphasized that this acquisition represents a pivotal step in meeting growing demand for their premium brands, accelerating innovation, and creating long-term shareholder value.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has scheduled its Q1 2025 financial results announcement for Tuesday, May 27, 2025, after market close.
The company will host a conference call to discuss the results on Wednesday, May 28, 2025, at 7:00 AM PT / 10:00 AM ET. Investors can join via local dial-in (+1 (289) 514 5100) or toll-free North America (+1 (800) 717 1738) using conference ID 34244.
Rubicon Organics (ROMJF) has appointed Glen Ibbott, former CFO of Aurora Cannabis, as its Interim Chief Financial Officer, effective May 15, 2025. Ibbott replaces Janis Risbin, who will transition to an advisory role. With over 25 years of leadership experience in publicly-traded companies, Ibbott is known for his significant role at Aurora Cannabis (2017-2024), where he drove rapid growth and achieved positive EBITDA. His experience includes senior finance roles at healthcare companies and a crucial role in QLT Inc.'s $500 million merger with Aegerion Pharmaceuticals.
Ibbott, who holds dual CPA designations and MBAs from Cornell and Queen's University, joins Rubicon as the company plans to scale new capacity and explore international markets. The company has initiated a search for a permanent CFO, considering both internal and external candidates.